44% growth, modest margins—execution risk on milk inflation and capex

Delivered result ₹973.4 Cr; 44% YoY growth rate matches

(333 / 973.4) = 34.2%; calculation confirmed

(144.89 / 973.4) = 14.9%; confirms EBITDA leverage from 12.24% prior year

Matches delivered ₹64.7 Cr, 6.6% NPM

(248.29 / 973.4) = 25.5%; growth rate and contrib consistent

Seasonal Q1 boost; growth rates credible for summer quarter

No prior public guidance to compare. Set tone of structural opportunity (paneer, proteins) and execution discipline (wait 2-3 months on pricing).

Product mix (paneer +34%, ice cream +45%, yogurt +153% QoQ) driving margin, not pricing. Leverage from value-add categories, not commodity milk.

5-year exclusive contract with private entity (post-COVID to supplement direct sourcing). Signals backup supply; marginal cost impact from aggregator but secured volume.

Post-COVID milk supply risk; long-term 5-year contract at controlled cost with private partner. Direct sourcing remains core; no aggregator margin leak. Extension of procurement network, not loss of margin.

Yes, 34% paneer growth driven by GST removal and state bans on analogue. Organized market growing from ~5% to 25%+ by FY30; Milky Mist 20% share in organized segment positions us well.

No B2B sales to QSRs; retail-focused only (general trade, modern trade, HoReCa). High-protein paneer growing steadily; only 5-7% penetration vs. 50% protein needs—large headroom.

Not dependent on liquid milk; 20+ value-add categories (paneer +34%, cheese +38%, ice cream +60%) drive margin. Pricing ability across portfolio offsets milk cost inflation.

10.5% price hike already implemented in Q1; prior year 11%. Freight cost has doubled, but own logistics (375 fleet vehicles) saves 18-20% vs. third-party. Waiting 2-3 months post-cost spike before next hike.

4.5-5% trade discount, 4.5-5% marketing/promotion. Post-GST, no change in net realization. All factors monitored closely; pricing ability retained.

Ice cream seasonal but category 60% growth Q1-specific. All other categories (paneer, yogurt, cheese) sustainably growing 30-40%. Q2-Q4 will be more normalized, but margin profile similar year-round.

Already producing 1 million liters cheese whey daily; extracting protein for internal + B2B/B2C sale. DHRHP (protein concentrate) coming 12-15 months; will unlock margin expansion significantly and bottom-line contribution.

Capex ₹650 Cr RHP + ₹500 Cr already funded via IPO. Sudden maintenance capex comfortable; no cash flow pressure. Free cash flowing even post-capex; will evaluate for next year onwards.

Procurement volume up 28% Q1 vs Q1 FY26 despite yield headwinds; expanding network, financing farmers via Kisan Credit, breeding/genetics/feed improvement. Backward integration focus.

~140 EBOs now (experimental); scaling cautiously in Tier 1/2 cities and semi-urban. 50,000+ visi coolers deployment over next 3 years is priority.

13.2 lakh liters per day procurement; landed cost INR45 per liter (INR41-42 to farmers + INR3-4 transport). Plant capacity: 3x FY26 numbers possible with MRP pricing and product mix.

South strong 44% growth; North 50% growth year-on-year. Gradual shift toward 60:40 expected over time. Maharashtra procurement initiated 6-7 months back; will reach 40% capacity utilization before plant commissioning.

Margin expansion from scale, product mix, pricing ability, and operational efficiency. Currently 14.9% EBITDA. Cannot confirm 18% target, but margin uplift expected. 0.5% leverage benefit anticipated from scale.

Based on organized market expansion (5-7% → 25%+) and Milky Mist 20% share in organized segment

Currently 14.8-14.9%; scale, product mix, and capacity utilization to drive. Management cautious on 18% ceiling.

Already funded via IPO; no cash flow pressure. Protein concentrate (12-15 month ramp) highest ROI.

Retail infrastructure expansion; phased rollout subject to market conditions

Milk costs rising (INR 41-42 base + INR 3 recent spike to farmers); management waiting 2-3 months before price hike. Q2-Q3 margin compression risk if costs stay elevated.

South India base (70% sales) drives dominance but concentration risk. North expansion (currently 30%) requires new distribution model, competition. If North growth falters, topline diversity at risk.

Ice cream sales peak in Q1-Q2 summer (45% volume, 60% revenue growth). Q3-Q4 monsoon/winter will see sharp decline. Revenue growth rate will normalize to 25-35% in H2; don't extrapolate 44%.

Protein concentrate plant delayed, capacity ramp below plan, or visi cooler adoption slower than expected would compress ROI and delay margin uplift. Plant delays push margin expansion timeline.

CFO explicitly declined to confirm 17-18% EBITDA margin target for FY30, even when analyst pushed. This suggests limited pricing power or commodity cost stickiness. 15% ceiling may be structural limit.